GlassScriptPhysician profile
Ross O Chavkin
NPI 1093754467
$3,864.17
in general payments reported to CMS, 2019-2025
9 companies · $1,076 in 2025
The $1,076 reported for 2025 was more than what 87% of Oral and Maxillofacial Surgery providers received nationally (typical 2025 total: $150).
See the full distribution for Oral and Maxillofacial Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $439 · 2020: $876 · 2021: $523 · 2022: $427 · 2023: $381 · 2024: $142 · 2025: $1,076.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,599.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,598.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohorizons Implant Systems INC. | $2,438.87 | 2019-2025 | Biohorizons, Biohorizons Dental Implants |
| Salvin Dental Specialties, INC. | $490.65 | 2019-2021 | |
| Straumann USA LLC | $459.21 | 2021-2025 | |
| Zimmer Biomet Holdings, INC. | $337.70 | 2019-2021 | |
| Zimvie INC. | $53.33 | 2023-2025 | |
| Implant Direct Sybron International LLC | $39.83 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $17.66 | 2022 | |
| Philips North America LLC | $14.04 | 2025 | Cordless Pf Mid End 3000 |
| Hu-Friedy Mfg. Co., LLC | $12.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ross Chavkin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.